Plus, a Top 2% analyst's call on a fallen biotech leader...
Oct 17, 2026
Oct 10, 2026
•
1 min read
Plus, a new Alzheimer's play with a brain-shuttle edge...
Oct 3, 2026
Plus, a vaccine maker weeks from its pivotal test....
